{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Nicolas Pythoud"}, {"accession": "MS:1000589", "name": "contact email", "value": "nicolas.pythoud@etu.unistra.fr"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Strasbourg"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Christine Carapito"}, {"accession": "MS:1000589", "name": "contact email", "value": "ccarapito@unistra.fr"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Laboratoire de Spectrom\u00e9trie de Masse BioOrganique (LSMBO), Universit\u00e9 de Strasbourg, CNRS, IPHC, UMR 7178, 25 Rue Becquerel, F-67087 Strasbourg, France"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DDA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DDA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DDA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DDA_Semi-fractionation.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DIA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DIA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DIA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Adalimumab_DIA_Semi-fractionation.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DDA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DDA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DDA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DDA_Semi-fractionation.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DIA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DIA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DIA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Bevacizumab_DIA_Semi-fractionation.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DDA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DDA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DDA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DDA_Semi-fractionation.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DIA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DIA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DIA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Nivolumab_DIA_Semi-fractionation.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DDA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DDA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DDA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DDA_Semi-fractionation.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DIA_ND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DIA_OLD.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DIA_OND.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/Trastuzumab_DIA_Semi-fractionation.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Adalimumab_ND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Adalimumab_OLD.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Adalimumab_OND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Adalimumab_SemiFrac.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Bevacizumab_ND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Bevacizumab_OLD.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Bevacizumab_OND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Bevacizumab_SemiFrac.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Nivolumab_ND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Nivolumab_OLD.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Nivolumab_OND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Nivolumab_SemiFrac.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Trastuzumab_ND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Trastuzumab_OLD.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Trastuzumab_OND.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/DDA_Trastuzumab_SemiFrac.zip"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Adalimumab_ND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Adalimumab_OLD.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Adalimumab_OND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Adalimumab_Semi-fractionation.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Bevacizumab_ND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Bevacizumab_OLD.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Bevacizumab_OND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Bevacizumab_Semi-fractionation.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Nivolumab_ND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Nivolumab_OLD.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Nivolumab_OND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Nivolumab_Semi-fractionation.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Trastuzumab_ND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Trastuzumab_OLD.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Trastuzumab_OND.sne"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668/directDIA_Trastuzumab_Semi-fractionation.sne"}], "description": "12%) quantification of major HCPs. Overall, a final global HCP amount of a few tens of ppm in these mAb samples was measured, while reaching a sensitivity down to the sub-ppm level. Thus, this straightforward and robust approach can be intended as a routine quality control for whichever Drug Products\u2019 analysis.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD019668"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD019668"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD019668"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Host cell proteins (HCP), Data-independent analysis (DIA), Quantification, Sample preparation, Mass spectrometry"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "33016074"}, {"accession": "MS:1002866", "name": "Reference", "value": "Pythoud N, Bons J, Mijola G, Beck A, Cianf\u00e9rani S, Carapito C. Optimized Sample Preparation and Data Processing of Data-Independent Acquisition Methods for the Robust Quantification of Trace-Level Host Cell Protein Impurities in Antibody Drug Products. J Proteome Res. 2020"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Cricetulus griseus"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10029"}]}], "title": "Optimized sample preparation, data processing of data-independent acquisition methods for the robust quantification of trace-level host cell protein impurities in drug products"}